Givaudan SA GIVN.SW
Composite 50/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 32/100 — a moderate mark against it.
Quality ranks 66/100 — a moderate point in its favour. Momentum ranks 63/100 — a moderate point in its favour. Balance-sheet strength ranks 54/100 — a slight point in its favour.
Growth ranks 32/100 — a moderate mark against it. Valuation ranks 32/100 — a moderate mark against it.
What the company does Givaudan SA is a Swiss specialty chemicals group focused on fragrance, beauty, taste, and wellbeing ingredients for consumer goods, split between Fragrance & Beauty and Taste & Wellbeing divisions.
Key financials Gross margin 44%, operating margin 19%, net margin 13%. ROE 22%, ROA 7%. Revenue down 2%, EPS down 20% year-over-year. Debt/Equity 1.11, net debt/EBITDA 2.91, dividend yield 2%.
Stock health Sideravia scores: Quality 57, Growth 35, Strength 38, Valuation 25, Momentum 59, Income 66. Piotroski F-Score 4/9, current ratio 1.29. 12-month return -6%, RSI 49.
Price vs fair value The stock trades at a PREMIUM of 43% to our fair-value estimate of 1886.21 and at a discount of 6% to the analyst 12-month target of 3476.33. - Fair-value premium of 43% versus Sideravia estimate (Sideravia) - Forward P/E 26 vs trailing 32 (Valuation) - PEG 4.67 signals stretched valuation (Valuation) - Growth percentile 35 indicates weak momentum (Growth) - Analyst target implies 6% upside (Analyst count 20)
Looking forward Forward P/E 26 and PEG 1.14 suggest valuation is pricing in moderate growth. Analysts see 6% upside to 3476 over the next 12 months.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.